Fresh Twist: India Stays Revocation Order On Novartis Ceritinib Patent

 
• By Anju Ghangurde

Appellate board stays previous order that rescinded the patent on ceritinib in India, giving Novartis the upper hand for now. The spotlight is now on procedural aspects and additional evidence/submission by challenger Natco and rebuttal by the Swiss multinational.

Patent Law Concept 3D Illustration
Another twist in Indian ceritinib patent case • Source: Shutterstock

More from Business

More from Scrip